Globus Medical, Inc. (GMED)
71.05
-10.39
(-12.76%)
USD |
NYSE |
Nov 06, 16:00
71.30
+0.25
(+0.35%)
After-Hours: 20:00
Globus Medical Research and Development Expense (Quarterly) : 34.53M for Sept. 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 34.53M |
| June 30, 2026 | 36.32M |
| March 31, 2026 | 36.51M |
| December 31, 2025 | 36.16M |
| September 30, 2025 | 38.07M |
| June 30, 2025 | 39.74M |
| March 31, 2025 | 32.97M |
| December 31, 2024 | 20.80M |
| September 30, 2024 | 35.38M |
| June 30, 2024 | 37.70M |
| March 31, 2024 | 44.67M |
| December 31, 2023 | 52.25M |
| September 30, 2023 | 29.33M |
| June 30, 2023 | 21.35M |
| March 31, 2023 | 21.08M |
| December 31, 2022 | 19.36M |
| September 30, 2022 | 18.70M |
| June 30, 2022 | 17.40M |
| March 31, 2022 | 17.41M |
| December 31, 2021 | 16.71M |
| September 30, 2021 | 15.85M |
| June 30, 2021 | 15.55M |
| March 31, 2021 | 14.92M |
| December 31, 2020 | 15.24M |
| September 30, 2020 | 14.42M |
| Date | Value |
|---|---|
| June 30, 2020 | 15.06M |
| March 31, 2020 | 15.40M |
| December 31, 2019 | 15.50M |
| September 30, 2019 | 14.51M |
| June 30, 2019 | 15.75M |
| March 31, 2019 | 14.32M |
| December 31, 2018 | 13.76M |
| September 30, 2018 | 15.53M |
| June 30, 2018 | 13.52M |
| March 31, 2018 | 12.69M |
| December 31, 2017 | 11.41M |
| September 30, 2017 | 10.89M |
| June 30, 2017 | 10.71M |
| March 31, 2017 | 10.67M |
| December 31, 2016 | 13.64M |
| September 30, 2016 | 10.26M |
| June 30, 2016 | 11.25M |
| March 31, 2016 | 10.20M |
| December 31, 2015 | 9.836M |
| September 30, 2015 | 9.409M |
| June 30, 2015 | 9.081M |
| March 31, 2015 | 8.656M |
| December 31, 2014 | 8.404M |
| September 30, 2014 | 8.146M |
| June 30, 2014 | 7.694M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Abbott Laboratories | 920.00M |
| Becton, Dickinson & Co. | 246.00M |
| Merit Medical Systems, Inc. | 22.39M |
| Teleflex, Inc. | 42.98M |
| Glaukos Corp. | 48.10M |